Bausch Health Companies Inc (BHC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bausch Health Companies Inc (BHC) has a cash flow conversion efficiency ratio of -0.213x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$230.00 Million ≈ $166.38 Million USD) by net assets (CA$-1.08 Billion ≈ $-782.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bausch Health Companies Inc (BHC) liquidity interval to measure how many days the company can operate on defensive assets alone.
Bausch Health Companies Inc - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how Bausch Health Companies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bausch Health Companies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bausch Health Companies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Droneshield Ltd
AU:DRO
|
-0.013x |
|
CETC Digital Technology Co Ltd
SHG:600850
|
0.020x |
|
Beijing Dabeinong Technology Group Co Ltd
SHE:002385
|
0.050x |
|
Farglory Land Development Co Ltd
TW:5522
|
0.056x |
|
China Yuchai International Limited
NYSE:CYD
|
N/A |
|
G2 Goldfields Inc.
TO:GTWO
|
-0.003x |
|
Shenzhen Forms Syntron Information Co Ltd
SHE:300468
|
0.070x |
|
S-1 Corp
KO:012750
|
0.070x |
Annual Cash Flow Conversion Efficiency for Bausch Health Companies Inc (1993–2025)
The table below shows the annual cash flow conversion efficiency of Bausch Health Companies Inc from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see Bausch Health Companies Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$376.31 Million ≈ $272.22 Million |
CA$1.38 Billion ≈ $997.34 Million |
3.664x | +173.87% |
| 2024-12-31 | CA$-322.00 Million ≈ $-232.93 Million |
CA$1.60 Billion ≈ $1.16 Billion |
-4.960x | +60.59% |
| 2023-12-31 | CA$-82.00 Million ≈ $-59.32 Million |
CA$1.03 Billion ≈ $746.53 Million |
-12.585x | -349.48% |
| 2022-12-31 | CA$260.00 Million ≈ $188.08 Million |
CA$-728.00 Million ≈ $-526.62 Million |
-2.800x | +93.32% |
| 2021-12-31 | CA$-34.00 Million ≈ $-24.60 Million |
CA$1.43 Billion ≈ $1.03 Billion |
-41.941x | -2383.93% |
| 2020-12-31 | CA$605.00 Million ≈ $437.65 Million |
CA$1.11 Billion ≈ $803.68 Million |
1.836x | +38.98% |
| 2019-12-31 | CA$1.14 Billion ≈ $821.77 Million |
CA$1.50 Billion ≈ $1.09 Billion |
1.321x | +147.80% |
| 2018-12-31 | CA$2.81 Billion ≈ $2.04 Billion |
CA$1.50 Billion ≈ $1.09 Billion |
0.533x | +38.40% |
| 2017-12-31 | CA$5.94 Billion ≈ $4.30 Billion |
CA$2.29 Billion ≈ $1.66 Billion |
0.385x | -39.86% |
| 2016-12-31 | CA$3.26 Billion ≈ $2.36 Billion |
CA$2.09 Billion ≈ $1.51 Billion |
0.641x | +75.54% |
| 2015-12-31 | CA$6.03 Billion ≈ $4.36 Billion |
CA$2.20 Billion ≈ $1.59 Billion |
0.365x | -13.58% |
| 2014-12-31 | CA$5.43 Billion ≈ $3.93 Billion |
CA$2.29 Billion ≈ $1.66 Billion |
0.422x | +112.08% |
| 2013-12-31 | CA$5.23 Billion ≈ $3.79 Billion |
CA$1.04 Billion ≈ $753.74 Million |
0.199x | +12.73% |
| 2012-12-31 | CA$3.72 Billion ≈ $2.69 Billion |
CA$656.58 Million ≈ $474.96 Million |
0.177x | +4.62% |
| 2011-12-31 | CA$4.01 Billion ≈ $2.90 Billion |
CA$676.47 Million ≈ $489.35 Million |
0.169x | +215.02% |
| 2010-12-31 | CA$4.91 Billion ≈ $3.55 Billion |
CA$263.19 Million ≈ $190.39 Million |
0.054x | -79.89% |
| 2009-12-31 | CA$1.35 Billion ≈ $979.73 Million |
CA$360.90 Million ≈ $261.07 Million |
0.266x | +56.71% |
| 2008-12-31 | CA$1.20 Billion ≈ $869.22 Million |
CA$204.32 Million ≈ $147.81 Million |
0.170x | -35.25% |
| 2007-12-31 | CA$1.30 Billion ≈ $938.82 Million |
CA$340.85 Million ≈ $246.57 Million |
0.263x | -35.35% |
| 2006-12-31 | CA$1.28 Billion ≈ $929.45 Million |
CA$521.93 Million ≈ $377.56 Million |
0.406x | +12.50% |
| 2005-12-31 | CA$1.38 Billion ≈ $997.94 Million |
CA$498.11 Million ≈ $360.32 Million |
0.361x | +77.00% |
| 2004-12-31 | CA$1.36 Billion ≈ $982.59 Million |
CA$277.09 Million ≈ $200.44 Million |
0.204x | -36.22% |
| 2003-12-31 | CA$881.60 Million ≈ $637.73 Million |
CA$281.98 Million ≈ $203.98 Million |
0.320x | -19.04% |
| 2002-12-31 | CA$845.69 Million ≈ $611.76 Million |
CA$334.10 Million ≈ $241.69 Million |
0.395x | +56.58% |
| 2001-12-31 | CA$1.13 Billion ≈ $814.58 Million |
CA$284.12 Million ≈ $205.53 Million |
0.252x | -41.54% |
| 2000-12-31 | CA$237.46 Million ≈ $171.77 Million |
CA$102.49 Million ≈ $74.14 Million |
0.432x | +131.96% |
| 1999-12-31 | CA$435.30 Million ≈ $314.89 Million |
CA$81.00 Million ≈ $58.59 Million |
0.186x | -82.23% |
| 1998-12-31 | CA$51.20 Million ≈ $37.04 Million |
CA$53.60 Million ≈ $38.77 Million |
1.047x | +1738.12% |
| 1997-12-31 | CA$75.50 Million ≈ $54.62 Million |
CA$4.30 Million ≈ $3.11 Million |
0.057x | +137.53% |
| 1996-12-31 | CA$36.90 Million ≈ $26.69 Million |
CA$-5.60 Million ≈ $-4.05 Million |
-0.152x | -107.12% |
| 1995-12-31 | CA$14.60 Million ≈ $10.56 Million |
CA$31.10 Million ≈ $22.50 Million |
2.130x | +530.85% |
| 1994-12-31 | CA$7.70 Million ≈ $5.57 Million |
CA$2.60 Million ≈ $1.88 Million |
0.338x | -58.19% |
| 1993-12-31 | CA$-2.60 Million ≈ $-1.88 Million |
CA$-2.10 Million ≈ $-1.52 Million |
0.808x | -- |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more